ATMOS Space Cargo develops reusable spacecraft and return logistics to establish circular infrastructure for spaceflight access. Their PHOENIX orbital transfer and return vehicle (OTRV) facilitates routine access to LEO, autonomous orbital operations, controlled re-entry, and rapid payload recovery. This service provides governments and industry with reliable and autonomous continuity for their space operations.

Charco Neurotech develops non-invasive wearable devices that employ neuromodulation technology to manage chronic pain and enhance mobility in patients with neurological disorders. Their products deliver measurable pain relief and improved functional outcomes for individuals with conditions such as Parkinson's disease and multiple sclerosis.

Constructive.Bio utilizes a dual-technology platform that combines de novo genome synthesis and engineered translation to create programmable biomolecules with high fidelity. This approach addresses the limitations of traditional biomanufacturing by enabling the production of customized bioproducts, including phage-resistant strains and next-generation therapeutics.

Creditas operates a fully digital platform that offers collateral‑backed personal loans—using vehicles or real estate—and payroll‑deductible credit for salaried workers, delivering rates as low as 1.09 % per month and terms up to 240 months. The platform also aggregates insurance policies from multiple carriers, provides real‑time multibank mortgage simulations, and supplies a zero‑cost employee‑benefits suite that can be integrated via open APIs for corporate partners.

Eleuthra Photonics develops multimodal nonlinear imaging technology for real-time digital histopathology, utilizing a single excitation laser to produce five imaging modalities without the need for staining. This approach significantly reduces the time required for tissue sample analysis while preserving molecular integrity, enhancing diagnostic accuracy for histopathologists and improving patient outcomes.

enaDyne develops non-thermal plasma catalysis reactors that convert CO2 into sustainable chemicals and eFuels, providing a method for recycling greenhouse gas emissions. This technology enables industries to produce climate-neutral alternatives to fossil-based chemicals at competitive costs, facilitating the transition to a circular economy.

Epoch Biodesign utilizes proprietary AI-designed enzymes to deconstruct waste materials at the molecular level. This biological process yields virgin-quality, recycled polymers, starting with nylon 6,6, at ultra-low emissions. The company is scaling this enzymatic recycling technology to support global manufacturing of circular materials.

Gemesys builds a neuromorphic processor that uses event‑driven spiking neural networks and hybrid analog‑digital compute units to deliver high‑throughput, low‑power AI inference and training. The chip’s massive on‑chip parallelism and built‑in learning reduce data movement and energy per operation, offering a scalable hardware accelerator for data‑center, edge, and embedded AI systems.

Healx utilizes generative AI to enhance and combine existing compounds for the rapid discovery of treatments for rare diseases, addressing the lack of effective therapies for over 90% of the 10,000 known rare diseases. By de-risking the drug development process, Healx increases the likelihood of successful outcomes and accelerates the delivery of new therapies to patients.

Hepstar offers an API-driven platform that enables travel providers to merchandise and sell personalized travel insurance and ancillary products. Their solution integrates seamlessly into booking flows, allowing airlines, online travel agencies, and other travel businesses to increase revenue through relevant upsells.

Provides zero-carbon industrial heat generation by using renewable electricity and thermal storage to achieve process temperatures up to 1,950°C. This technology replaces fossil fuel combustion in energy-intensive industries like cement, steel, glass, and chemicals, offering a cost-competitive alternative to natural gas while supporting grid stability.

This SaaS platform manages e-commerce returns to enhance customer experience and reduce operational costs. It utilizes AI and data insights to convert returns into exchanges, cross-sells, or gift cards, thereby minimizing refunds. The system integrates with existing ecosystems to streamline logistics and provide actionable data for product development.

The startup develops enterprise software that provides transportation scenario tools for applications in fleet management, infrastructure operations, and transportation planning. This technology enables clients to optimize mobility decisions by simulating various transport scenarios, improving operational efficiency and resource allocation.

Inephany develops an AI-driven optimiser designed to enhance the efficiency of training neural networks and Large Language Models (LLMs). This technology enables customers to achieve higher model performance using significantly less data and compute resources. The result is accelerated innovation through reduced training times and lower operational costs.

iPronics provides a rack‑ready silicon photonic optical switch (iPronics ONE) that can reconfigure network topologies in sub‑millisecond intervals, delivering lossless, low‑latency optical circuit switching for AI training and inference. The switch’s programmable photonic unit cells, built‑in telemetry, and Python APIs enable software‑defined control, reducing power consumption by up to three times and improving cost‑to‑capacity by 25× compared with traditional electronic switches, thereby increasing GPU utilization and lowering data‑center operating costs.

Natrx provides a technology platform that utilizes nature-based solutions, such as ExoForms™, to enhance coastal resilience and restore ecosystems. The platform addresses the challenges of habitat degradation and climate change by offering cost-effective, measurable strategies for landscape-scale restoration.

Nuclera's eProtein Discovery system utilizes cell-free protein synthesis and digital microfluidics to automate the screening, expression, and purification of proteins, delivering active protein samples in under 48 hours. This technology enables researchers to rapidly access and prototype target proteins, significantly accelerating drug discovery workflows.

Nu Quantum is developing the Entanglement Fabric, a networking architecture that integrates Quantum Processing Units through a Qubit-Photon Interface to create scalable, entangled qubit networks. This technology enables datacentre-scale quantum computing by facilitating modular hardware and software scaling, addressing the need for significantly more powerful quantum compute systems.

OKAPIOrbits provides end-to-end Space Traffic Management solutions, including risk prediction and collision avoidance software for satellites. Their technology addresses the increasing risk of satellite collisions and space debris by optimizing mission design and ensuring compliance with debris mitigation requirements.

Om provides access to massive, internally generated datasets detailing proteome-wide small molecule binding data. Researchers can programmatically query billions of protein and small molecule interaction data points to identify therapeutic opportunities instantly. The platform leverages synthetic biology and pico-scale engineering to accelerate the transition from hypothesis to launching a discovery program.

Ori Biotech has developed the IRO® platform, a fully automated and standardized manufacturing system for cell and gene therapies that enhances biological performance while minimizing batch failures and reducing costs. This technology addresses the challenges of high manufacturing costs and low throughput, enabling scalable production and wider patient access to lifesaving treatments.

Paragraf manufactures graphene-based electronic devices, including Graphene Field-Effect Transistors and Hall Sensors, using contamination-free direct deposition technology. These devices enhance molecule sensing accuracy and sensitivity in various applications, such as healthcare and cryogenics, while improving safety in electric vehicles through advanced magnetic field detection.

The startup develops a healthcare application that utilizes artificial intelligence to personalize the management of menopausal symptoms through evidence-based information and treatment options. This platform enables women to effectively track their menopause journey and mitigate the risk of future chronic diseases.

PhoreMost utilizes its proprietary SITESEEKER® technology to identify and target previously undruggable proteins, focusing on novel therapeutic candidates in oncology and Targeted Protein Degradation (TPD). The company collaborates with industry partners to develop effective treatments for challenging diseases, enhancing the druggable space in the pharmaceutical landscape.